AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for chronic ...

AstraZeneca has signed a deal worth up to $5.2bn to work with a Chinese biotech company using AI to develop new treatments for chronic diseases.

A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A stra ze neca,” means “a road to death” in Latin.

AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ongoing $3.5 billion investment in American innovation.

Tariffs are "certainly not material long term," Soriot said, adding that AstraZeneca will rely on the existing global network to shift manufacturing as needed.

The latest trading day saw Astrazeneca (AZN) settling at $64.90, representing a -1.35% change from its previous close.

AstraZeneca saw 18% revenue growth in 2024, boosted by key drugs and global innovation. See here to know why we recommend a buy on AZN stock.

AstraZeneca scraps £450m vaccine plant in Liverpool after Labour funding cut The pharmaceutical giant says the new Labour government has offered less investment than their Conservative predecessors.

Achilles Therapeutics transferred TRACERx data and samples to AstraZeneca, finalizing a strategic review and receiving $12M.

AstraZeneca expects a sales hit in China, one of its most important international markets. The drugmaker's issues in China have weighed heavily on its performance of late, and its stock is down by ...

AstraZeneca and Daiichi Sankyo have shared the data they believe can secure approval for datopotamab deruxtecan (Dato-DXd) at the second attempt. The partners showed off subgroup overall survival ...

A closely watched cancer drug from AstraZeneca and Daiichi Sankyo could take longer to reach the market.